Fundraising FoxPRD Therapeutics
Tokyo, JP · 4 known investors
Find your way into PRD Therapeutics
Sign up to see every warm intro you have to PRD Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the PRD Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
PRD Therapeutics is a drug-discovery startup developing first-in-class oral SOAT2-selective inhibitors (PRD compounds derived from pyripyropene A) to regulate lipid metabolism. Its lead program targets the rare disease homozygous familial hypercholesterolemia (HoFH), with planned expansion to MASH/MASLD and other lipid-metabolism disorders.
Founders & leadership
Investors · 4
How we know: JIC Venture Growth Investments's portfolio page · funding news · press coverage · Not right? Tell us
How we know: funding news · press coverage · Not right? Tell us
How we know: funding news · press coverage · Not right? Tell us
How we know: funding news · press coverage · Not right? Tell us
Frequently asked questions
- What does PRD Therapeutics do?
- PRD Therapeutics is a drug-discovery startup developing first-in-class oral SOAT2-selective inhibitors (PRD compounds derived from pyripyropene A) to regulate lipid metabolism. Its lead program targets the rare disease homozygous familial hypercholesterolemia (HoFH), with planned expansion to MASH/MASLD and other lipid-metabolism disorders.
- Who founded PRD Therapeutics?
- PRD Therapeutics was founded by 細田 莞爾, 供田 洋.
- Who are PRD Therapeutics's investors?
- PRD Therapeutics's investors include JIC Venture Growth Investments, JAFCO Group, Mizuho Capital, SMBC Venture Capital.
- Where is PRD Therapeutics headquartered?
- PRD Therapeutics is headquartered in Tokyo, JP.